Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-25-058898
Filing Date
2025-06-12
Accepted
2025-06-12 16:20:09
Documents
12
Period of Report
2025-06-05
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2517794d1_8ka.htm   iXBRL 8-K/A 29066
  Complete submission text file 0001104659-25-058898.txt   191028

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gdnsf-20250605.xsd EX-101.SCH 3035
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE gdnsf-20250605_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gdnsf-20250605_pre.xml EX-101.PRE 22371
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2517794d1_8ka_htm.xml XML 3347
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Vireo Growth Inc. (Filer) CIK: 0001771706 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-56225 | Film No.: 251042921
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)